Karri Penttilä

800 total citations
45 papers, 560 citations indexed

About

Karri Penttilä is a scholar working on Hematology, Oncology and Mechanical Engineering. According to data from OpenAlex, Karri Penttilä has authored 45 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 11 papers in Oncology and 8 papers in Mechanical Engineering. Recurrent topics in Karri Penttilä's work include Hematopoietic Stem Cell Transplantation (9 papers), Multiple Myeloma Research and Treatments (5 papers) and Metallurgical Processes and Thermodynamics (5 papers). Karri Penttilä is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Multiple Myeloma Research and Treatments (5 papers) and Metallurgical Processes and Thermodynamics (5 papers). Karri Penttilä collaborates with scholars based in Finland, Netherlands and Germany. Karri Penttilä's co-authors include Ilkka Penttilä, Esa Jantunen, Tapio Rantanen, Taru Kuittinen, T. Nousiainen, Eija Mahlamäki, Joonho Lee, Pertti Koukkari, Hirotaro Mori and Toshihiro Tanaka and has published in prestigious journals such as The Oncologist, British Journal of Clinical Pharmacology and Process Safety and Environmental Protection.

In The Last Decade

Karri Penttilä

42 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karri Penttilä Finland 13 193 125 114 71 68 45 560
Jae Seok Lee South Korea 20 84 0.4× 227 1.8× 227 2.0× 203 2.9× 56 0.8× 85 1.2k
Stephen Robinson United Kingdom 13 107 0.6× 179 1.4× 201 1.8× 329 4.6× 20 0.3× 41 1.1k
Takeshi Hisamatsu Japan 16 53 0.3× 298 2.4× 287 2.5× 45 0.6× 30 0.4× 31 820
Takahiro Yamauchi Japan 13 104 0.5× 99 0.8× 145 1.3× 16 0.2× 12 0.2× 91 542
Kazuo Maeda Japan 17 112 0.6× 115 0.9× 122 1.1× 60 0.8× 31 0.5× 64 799
Yosuke Nakagawa Japan 13 58 0.3× 40 0.3× 118 1.0× 78 1.1× 43 0.6× 46 732
Yusuke Ozaki Japan 9 58 0.3× 27 0.2× 49 0.4× 63 0.9× 10 0.1× 41 448
Yusuke Araki Japan 9 406 2.1× 16 0.1× 54 0.5× 20 0.3× 37 0.5× 24 676
Li Bao China 13 137 0.7× 87 0.7× 117 1.0× 20 0.3× 19 0.3× 75 458

Countries citing papers authored by Karri Penttilä

Since Specialization
Citations

This map shows the geographic impact of Karri Penttilä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karri Penttilä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karri Penttilä more than expected).

Fields of papers citing papers by Karri Penttilä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karri Penttilä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karri Penttilä. The network helps show where Karri Penttilä may publish in the future.

Co-authorship network of co-authors of Karri Penttilä

This figure shows the co-authorship network connecting the top 25 collaborators of Karri Penttilä. A scholar is included among the top collaborators of Karri Penttilä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karri Penttilä. Karri Penttilä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kuittinen, Outi, Hanne Kuitunen, Kaija Vasala, et al.. (2023). CD34+ Cell Mobilization, Autograft Cellular Composition and Outcome in Mantle Cell Lymphoma Patients. Transfusion Medicine and Hemotherapy. 50(5). 428–437. 1 indexed citations
3.
Tzogani, Kyriaki, Karri Penttilä, Johanna Lähteenvuo, et al.. (2020). EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma. The Oncologist. 26(1). 70–76. 32 indexed citations
4.
Partanen, Anu, Antti Ropponen, Outi Kuittinen, et al.. (2020). Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study. Leukemia & lymphoma. 61(9). 2082–2092. 11 indexed citations
5.
Tzogani, Kyriaki, Odoardo Maria Olimpieri, Daniela Melchiorri, et al.. (2019). European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. ESMO Open. 4(5). e000570–e000570. 12 indexed citations
6.
Pauwels, Kim, Isabelle Huys, Minne Casteels, et al.. (2017). Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012. Orphanet Journal of Rare Diseases. 12(1). 36–36. 7 indexed citations
7.
Penttilä, Ilkka, et al.. (2016). Methods, units and quality requirements for the analysis of haemoglobin A1cin diabetes mellitus. World Journal of Methodology. 6(2). 133–133. 16 indexed citations
8.
Laitinen, Antero, et al.. (2015). Physical solvent extraction of levulinic acid from dilute aqueous solution with 2-methyltetrahydrofuran. Separation Science and Technology. 51(3). 465–473. 18 indexed citations
9.
Penttilä, Ilkka, et al.. (2015). Hemoglobin A1c reported in units and diagnostic cut-offs in relation to the international recommendations. Clinical Chemistry and Laboratory Medicine (CCLM). 53(9). e215–7. 2 indexed citations
10.
Penttilä, Ilkka, et al.. (2011). Adaptation of the Diazyme Direct Enzymatic HbA1c Assay for a microplate reader at room temperature. Clinical Chemistry and Laboratory Medicine (CCLM). 49(7). 1221–1223. 5 indexed citations
11.
Penttilä, Karri, et al.. (2010). Modeling of Incineration of Spent Ion Exchange Resins of Boiling Water and Pressurized Water Nuclear Reactors. Nuclear Technology. 172(2). 230–236. 10 indexed citations
12.
Jantunen, Esa, Karri Penttilä, Marja Pyörälä, et al.. (2010). Addition of plerixafor to a chemotherapy plus G-CSF mobilization in hard-to-mobilize patients. Bone Marrow Transplantation. 46(2). 308–309. 20 indexed citations
13.
Varis, Tommi, et al.. (2010). Optimised selection of new protective coatings for biofuel boiler applications. Materials and Corrosion. 62(7). 642–649. 5 indexed citations
14.
Koukkari, Pertti, et al.. (2009). New dynamics for kiln chemistry. 117–123. 1 indexed citations
15.
Ervasti, Mari, et al.. (2008). Diagnostic, clinical and laboratory turnaround times in troponin T testing. Clinical Chemistry and Laboratory Medicine (CCLM). 46(7). 1030–2. 5 indexed citations
16.
Heikinheimo, Liisa, D. Baxter, Klaus Hack, et al.. (2006). Optimisation of in-service performance of boiler steels by modelling high-temperature corrosion. Materials and Corrosion. 57(3). 230–236. 8 indexed citations
17.
Penttilä, Karri, Heli Koukkunen, Matti Halinen, et al.. (2002). Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain. Clinical Biochemistry. 35(8). 647–653. 20 indexed citations
18.
Koukkunen, Heli, Karri Penttilä, Matti Halinen, et al.. (1998). Troponin T and creatinine kinase isoenzyme MB mass in the diagnosis of myocardial infarction. Annals of Medicine. 30(5). 488–496. 9 indexed citations
19.
Koukkari, Pertti, Karri Penttilä, & Justin Salminen. (1998). Chemsheet - a versatile worksheet tool for thermodynamic process simulation. 1 indexed citations
20.
Kröger, Heikki, et al.. (1995). Ultrasound attenuation of the calcaneus in normal subjects and in patients with wrist fracture. Acta Orthopaedica Scandinavica. 66(1). 47–52. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026